Circulating MicroRNAs as a Marker for Liver Injury in Human Immunodeficiency Virus Patients

被引：64

作者：

Anadol, Evrim ^{[1
]}

Schierwagen, Robert ^{[1
]}

Elfimova, Natalia ^{[2
]}

Tack, Katharina ^{[1
]}

Schwarze-Zander, Carolynne ^{[1
,3
]}

Eischeid, Hanna ^{[2
]}

Noetel, Andrea ^{[2
]}

Boesecke, Christoph ^{[1
,3
]}

Jansen, Christian ^{[1
]}

Dold, Leona ^{[1
]}

Wasmuth, Jan-Christian ^{[1
,3
]}

Strassburg, Christian P. ^{[1
]}

Spengler, Ulrich ^{[1
,3
]}

Rockstroh, Juergen Kurt ^{[1
,3
]}

Odenthal, Margarete ^{[2
]}

Trebicka, Jonel ^{[1
]}

机构：

[1] Univ Bonn, Dept Internal Med 1, Bonn, Germany

[2] Univ Cologne, Dept Pathol, Cologne, Germany

[3] Partner Site Bonn Cologne, German Ctr Infect Res DZIF, Bonn, Germany

来源：

HEPATOLOGY | 2015年 / 61卷 / 01期

关键词：

HEPATITIS-C VIRUS; SIMPLE NONINVASIVE INDEX; HIV-INFECTED PATIENTS; FIBROSIS PROGRESSION; RISK-FACTORS; MONOINFECTED PATIENTS; HIV/HCV COINFECTION; EXPRESSION; DISEASE; THERAPY;

D O I：

10.1002/hep.27369

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

100201 [内科学];

摘要：

Human immunodeficiency virus (HIV) and hepatitis virus coinfection amplify and accelerate hepatic injury. MicroRNAs (miRNAs) are small regulatory RNAs suggested as biomarkers for liver injury. We analyzed the circulating levels of miRNAs in HIV patients with regard to the extent and etiology of liver injury. Total RNA was extracted from 335 serum samples of HIV patients and 22 healthy control participants using Qiazol. Comprehensive polymerase chain reaction (PCR) array analyses (768 miRNA) were performed in serum samples of eight HIV, eight HIV/HCV (hepatitis C virus), six HCV patients, and three healthy controls. Reverse transcription (RT)-PCR measured levels of miRNA-122, miRNA-22, and miRNA-34a in serum samples of 335 patients and 19 healthy control participants. Liver injury and fibrosis in these patients were defined using aspartate aminotransferase (AST) levels, fibrosis-4 (FIB-4) index and AST-to-platelet ratio index (APRI) score. The miRNA pattern of HIV/HCV samples showed altered expression of 57 and 33 miRNA compared to HCV and HIV infection, respectively. miRNA-122, miRNA-22, and miRNA-34a were highly up-regulated in HIV/HCV patients. Analyzing the entire cohort, these miRNAs were correlated with liver function tests and were independent predictors of liver injury (AST >2 x ULN). miRNA-122 and miRNA-22 were associated with relevant fibrosis (FIB-4 >1.45; APRI >1). Circulating levels of miRNA-122 were independent predictors for relevant fibrosis in HIV patients. Interestingly, miRNA-122 and miRNA-34a levels were higher in HIV/HCV patients, miRNA-22 levels were highest in HIV/HBV patients, and circulating levels of miRNA-34a correlated positively with illicit drug use and ethanol consumption. Conclusion: Circulating miRNA-122, miRNA-22, and miRNA-34a correlates with the etiology of liver injury in HIV patients. These biomarkers not only mirror different mechanisms of hepatic injury, but also are independent predictors of liver injury in HIV patients. (Hepatology 2015;61:46-55)

引用

页码：46 / 55

页数：10

共 46 条

[1]

Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection [J].